R8.71 HIV-1 RCL Positive Control Virus

Product Description

R8.71 HIV-1 RCL Positive Control Virus is an attenuated HIV-1-derived control material designed for replication competent lentivirus (RCL) assay development, assay qualification, and quality control workflows. This product supports lentiviral vector safety testing applications in academic, biotechnology, and gene therapy research laboratories. The control virus is suitable for validating amplification and detection workflows, including p24 ELISA, RT-qPCR, and permissive cell-based RCL assays. Customizable aliquot sizes and titers are available upon request. The material is manufactured for research use only (RUO) and shipped frozen on dry ice to ensure long-term stability and performance consistency.

Biosafety Requirements

This product is intended for use only by qualified laboratories with appropriate biosafety infrastructure, training, and institutional approvals for handling HIV-derived materials. Customers are responsible for ensuring compliance with all applicable local, state, federal, and institutional regulations governing the use, storage, transport, and disposal of biohazardous materials.

At a minimum, users should:

• Handle the material in a laboratory operating at Biosafety Level 2 (BSL-2) or higher with enhanced precautions appropriate for HIV-derived materials
• Ensure personnel are trained in bloodborne pathogen handling procedures and lentiviral biosafety practices
• Follow institutional biosafety committee (IBC) requirements and approvals where applicable
• Use appropriate personal protective equipment (PPE) and engineering controls, including certified biological safety cabinets
• Properly decontaminate and dispose of all waste materials according to institutional and governmental regulations

This material is supplied for Research Use Only (RUO) and is not intended for human or veterinary use, diagnostic procedures, or therapeutic applications.